Tardive dyskinesia (TD) is an involuntary movement disorder caused by long-term dopamine-blocking medications. Prolonged use may create chemical imbalances in brain areas controlling movement.
In a pioneering study, from the Expertise Centre for Movement Disorders in Groningen, Machine Learning, a core area of artificial intelligence (AI), is successfully used for the first time to ...
A study by an international team of researchers led by Santa Barbara City College (SBCC) Psychology Department ...
Tardive dyskinesia (TD) is a rare movement disorder linked to long-term use of certain medications, especially dopamine receptor-blocking drugs like antipsychotics. Early TD symptoms often start with ...
A new study of movement disorders published in the International Journal of Public Health was led by Santa Barbara City ...
Kristin Weiland is a documentary film producer and writer with a background in crisis management and ethnographic research. She specializes in investigative and social impact documentary projects, and ...
The medications approved by the Food and Drug Administration (FDA) for treating Huntington’s disease chorea are Xenazine (tetrabenazine), Ingrezza (valbenazine) and Austedo (deuterabenazine).
Recognizing symptoms and confirming diagnosis Movement disorders often show overlapping symptoms, making it difficult for doctors to make the correct diagnosis. Patients may also experience multiple ...